Gene · 6921
Papers1,693
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
421 to 440 of 1,693
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| A selective WDR5 degrader inhibits acute myeloid leukemia in patient-derived mouse models. | Sci Transl Med | 2021 | 34586829 | PubTator, text mining | PubMed |
| Hsp90 chaperone code and the tumor suppressor VHL cooperatively regulate the mitotic checkpoint. | Cell Stress Chaperones | 2021 | 34586601 | PubTator, text mining | PubMed |
| Proteasomal Degradation of Zn-Dependent Hdacs: The E3-Ligases Implicated and the Designed Protacs That Enable Degradation. | Molecules | 2021 | 34577077 | PubTator, text mining | PubMed |
| Loss of Von Hippel-Lindau (VHL) Tumor Suppressor Gene Function: VHL-HIF Pathway and Advances in Treatments for Metastatic Renal Cell Carcinoma (RCC). | Int J Mol Sci | 2021 | 34575959 | PubTator, text mining | PubMed |
| AMPK-mTOR Signaling and Cellular Adaptations in Hypoxia. | Int J Mol Sci | 2021 | 34575924 | PubTator, text mining | PubMed |
| The Interplay Among HIV, LINE-1, and the Interferon Signaling System. | Front Immunol | 2021 | 34566998 | PubTator, text mining | PubMed |
| Indomethacin-based PROTACs as pan-coronavirus antiviral agents. | Eur J Med Chem | 2021 | 34534839 | PubTator, text mining | PubMed |
| Discovery of a Novel BCL-XL PROTAC Degrader with Enhanced BCL-2 Inhibition. | J Med Chem | 2021 | 34533954 | PubTator, text mining | PubMed |
| Altered topological properties of brain functional networks in drug-resistant epilepsy patients with vagus nerve stimulators. | Seizure | 2021 | 34521062 | PubTator, text mining | PubMed |
| CUL5-ARIH2 E3-E3 ubiquitin ligase structure reveals cullin-specific NEDD8 activation. | Nat Chem Biol | 2021 | 34518685 | PubTator, text mining | PubMed |
| A nine-hub-gene signature of metabolic syndrome identified using machine learning algorithms and integrated bioinformatics. | Bioengineered | 2021 | 34516309 | PubTator, text mining | PubMed |
| Clear Cell Papillary Renal Cell Carcinoma Shares Distinct Molecular Characteristics and may be Significantly Associated With Higher Risk of Developing Second Primary Malignancy. | Pathol Oncol Res | 2021 | 34512202 | PubTator, text mining | PubMed |
| Establishment of an Immune-Related Gene Signature for Risk Stratification for Patients with Glioma. | Comput Math Methods Med | 2021 | 34497663 | PubTator, text mining | PubMed |
| Genomics and metabolomics of early-stage thioacetamide-induced liver injury: An interspecies study between guinea pig and rat. | Toxicol Appl Pharmacol | 2021 | 34492290 | PubTator, text mining | PubMed |
| Von Hippel-Lindau gene single nucleotide polymorphism (rs1642742) may be related to the occurrence and metastasis of HBV-related hepatocellular carcinoma. | Medicine (Baltimore) | 2021 | 34477178 | PubTator, text mining | PubMed |
| Identification of the similarly expressed genes in patients with polycystic ovary syndrome and transsexuals. | Medicine (Baltimore) | 2021 | 34477128 | PubTator, text mining | PubMed |
| Regulation of topoisomerase II stability and activity by ubiquitination and SUMOylation: clinical implications for cancer chemotherapy. | Mol Biol Rep | 2021 | 34476738 | PubTator, text mining | PubMed |
| Methods to Study the Unique SOCS Box Domain of the Rab40 Small GTPase Subfamily. | Methods Mol Biol | 2021 | 34453716 | PubTator, text mining | PubMed |
| Molecular Pathways Involved in the Development of Congenital Erythrocytosis. | Genes (Basel) | 2021 | 34440324 | PubTator, text mining | PubMed |
| Characterization of an A3G-VifHIV-1-CRL5-CBFβ Structure Using a Cross-linking Mass Spectrometry Pipeline for Integrative Modeling of Host-Pathogen Complexes. | Mol Cell Proteomics | 2021 | 34389466 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6921/papers?page=22